Teva to Buy Allergan Generics in $40.5 Billion Deal (NYSE: TEVA)

Teva to Buy Allergan Generics: Teva announced Monday it will buy Allergan Generics in a deal valued at $40.5 billion.

The move further...

Pages 1 of 1